drugset / Trial / NCT00639808
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis
RandomizedCrossoverTriple-blindTreatment
Summary
The purpose of this study is to determine whether TZP-101 is safe in people with diabetes. Also to determine if TZP-101 is effective in increasing the gastric emptying rate in diabetic patients.
Timeline
- Start
- 2006-08
- Primary completion
- 2007-07
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ulimorelin | Small molecule | 160 ug/kg | Intravenous |
| Subject | Ulimorelin | Small molecule | 320 ug/kg | Intravenous |
| Subject | Ulimorelin | Small molecule | 600 ug/kg | Intravenous |